December 12, 2024 - 21:16

In a significant advancement for the paper and pulp industry, Voith has introduced its latest headbox technology, the MasterJet 4Tec. This cutting-edge solution promises to enhance the quality of paper production by achieving an impressive reduction of over 30% in streaks within the jet.
The MasterJet 4Tec is designed to optimize the flow of pulp, ensuring a more uniform distribution across the paper machine. This innovation addresses a common challenge faced by manufacturers, as streaks can lead to defects and inconsistencies in the final product. By minimizing these imperfections, Voith aims to help companies improve their production efficiency and reduce waste.
Moreover, the new headbox technology is expected to contribute to more sustainable manufacturing processes by lowering energy consumption and raw material usage. As the industry continues to evolve, Voith's MasterJet 4Tec stands out as a pivotal development that could redefine operational standards in paper production.
April 2, 2026 - 20:34
Moog Technology Successfully Steers Artemis II LaunchThe upcoming Artemis II mission, NASA`s first crewed lunar flight in over fifty years, will rely on critical steering technology developed by Moog Inc. The company`s proven Reaction Control System ...
April 2, 2026 - 06:21
Latham Adds Leading Data & Technology Transactions Partner in Bay AreaGlobal law firm Latham & Watkins has expanded its capabilities in the rapidly evolving digital sector with the addition of John McGaraghan as a partner in its Data & Technology Transactions...
April 1, 2026 - 18:24
New AI technology coming to ECC to meet federal deadlineEl Camino College is implementing new artificial intelligence technology to ensure its digital course materials meet stringent federal accessibility standards by the April 24 deadline. The...
April 1, 2026 - 07:34
Designing for Scale: Building Commercial Readiness Into CGT Manufacturing From Day OneThe journey from a promising clinical result to reliable, commercial-scale manufacturing remains a formidable hurdle for cell and gene therapy (CGT) developers. Industry experts now emphasize that...